PRMT5 and neoplasm: Signal transducer and activator of transcription (STAT) is kept in an activated state in non-small cell lung cancer cells (NSCLC) through PRMT5 methylation, which also controls STAT’s transcriptional activity and tumour growth and cancer stem cell maintenance support.